Advertisement
Screener

BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) Proceeds from Contributed Capital

2.8 / 5 stars · 68/120 Roast Me

BIOFORCE NANOSCIENCES HOLDINGS, INC. Proceeds from Contributed Capital

BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) reported Proceeds from Contributed Capital of $100 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-02.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromContributedCapital · last filed 2022-11-02

  • BIOFORCE NANOSCIENCES HOLDINGS, INC. proceeds from contributed capital for the quarter ending 2019-12-31 was $16.22K, a 53.86% increase year-over-year.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. proceeds from contributed capital for the quarter ending 2019-09-30 was $7.76K, a 26.75% decline year-over-year.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. proceeds from contributed capital for the quarter ending 2019-06-30 was $10.74K, a 59.50% decline year-over-year.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. proceeds from contributed capital for the quarter ending 2019-03-31 was $13.16K, a 55.93% decline year-over-year.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. proceeds from contributed capital for fiscal 2019 was $47.89K, a 38.24% decline from fiscal 2018.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. proceeds from contributed capital for fiscal 2018 was $77.53K, a 199.38% increase from fiscal 2017.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. proceeds from contributed capital for fiscal 2017 was $25.90K.
Period endProceeds from Contributed Capital 3 monthProceeds from Contributed Capital 6 monthProceeds from Contributed Capital 9 monthProceeds from Contributed Capital 12 month
2022-09-30$100.00
10-Q · filed 2022-11-02
2019-12-31$16.22K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$23.98K
derived: sum of 2 quarters · filed 2021-02-16
$34.72K
derived: sum of 3 quarters · filed 2021-02-16
$47.89K
10-K · filed 2021-02-16
2019-09-30$7.76K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23
$18.50K
derived: sum of 2 quarters · filed 2020-10-23
$31.66K
10-Q · filed 2020-10-23
$42.21K
derived: sum of 4 quarters · filed 2020-10-23
2019-06-30$10.74K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22
$23.91K
10-Q · filed 2020-07-22
$34.45K
derived: sum of 3 quarters · filed 2020-07-22
$45.04K
derived: sum of 4 quarters · filed 2020-07-22
2019-03-31$13.16K
10-Q · filed 2020-05-04
$23.71K
derived: sum of 2 quarters · filed 2020-05-04
$34.30K
derived: sum of 3 quarters · filed 2020-05-04
$60.83K
derived: sum of 4 quarters · filed 2020-05-04
2018-12-31$10.54K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-09
$21.13K
derived: sum of 2 quarters · filed 2020-03-09
$47.66K
derived: sum of 3 quarters · filed 2020-03-09
$77.53K
10-K/A · filed 2020-03-09
2018-09-30$10.59K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$37.12K
derived: sum of 2 quarters · filed 2019-11-05
$66.99K
10-Q · filed 2019-11-05
$78.70K
derived: sum of 4 quarters · filed 2019-11-05
2018-06-30$26.53K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-22
$56.40K
10-Q · filed 2019-07-22
$68.11K
derived: sum of 3 quarters · filed 2019-07-22
2018-03-31$29.87K
10-Q · filed 2019-04-30
$41.58K
derived: sum of 2 quarters · filed 2019-04-30
2017-12-31$11.71K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$25.90K
10-K · filed 2019-03-29
2017-09-30$14.19K
10-Q · filed 2018-10-24